Concordia Healthcare (CHEHF) 75.8400 $CHEHF
OTC Markets Group Congratulates Concordia Healthcare Corporation on NASDAQ Listing
PR Newswire - Mon Jun 29, 3:30PM CDT
OTC Markets Group Inc. (OTCQX: OTCM) is pleased to congratulate Concordia Healthcare Corporation, a Canada-based specialty healthcare company, on its NASDAQ listing. Prior to joining NASDAQ, Concordia traded on the OTCQX® Best Marketplace operated by OTC Markets Group.
Concordia Healthcare Corp. Reports Results of Annual General Meeting of Shareholders
PR Newswire - Thu Jun 25, 4:00PM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company"
(TSX: CXR) (OTCQX: CHEHF), announced today that all of the nominees listed in the Company's Management Information Circular, dated May 25, 2015, for the 2015 Annual General Meeting of shareholders held on June 25, 2015, in Toronto, Ontario, (the "Meeting" were elected as members of Concordia's Board of Directors ("Board". The five (5) candidates nominated for election were elected by a majority of the shareholders present in person or represented by proxy at the Meeting, as follows:
CXR.TO: 93.51 (+5.21)
Concordia Healthcare Corp. to Commence Trading on NASDAQ Global Select Market Under Symbol "CXRX"
CNW Group - Thu Jun 25, 6:00AM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company" (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced that its common shares will begin trading on the NASDAQ Global Select Market® ("NASDAQ" on June 29, 2015 under the symbol CXRX.
CXR.TO: 93.51 (+5.21)
Concordia Healthcare Announces Filing for a U.S. Listing
PR Newswire - Tue Jun 02, 6:00AM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company" (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced that it has filed an application to list its common shares on the NASDAQ Global Select Market® ("NASDAQ", and has filed the requisite registration documentation with the U.S. Securities and Exchange Commission.
CXR.TO: 93.51 (+5.21)
Concordia Healthcare Announces Changes to the Board of Directors, Management Team and Auditors
CNW Group - Mon May 25, 4:24PM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company" (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced several key changes to the Company's board of directors (the "Board" and management team.
CXR.TO: 93.51 (+5.21)
Concordia Healthcare Corp. Announces First Quarter 2015 Results
CNW Group - Thu May 14, 4:48PM CDT
- First quarter 2015 revenue increase of 117% compared to the first quarter of 2014 -
CXR.TO: 93.51 (+5.21)
Concordia Healthcare Corp. works to expand treatment options for patients with rare cancers
CNW Group - Thu May 07, 6:00AM CDT
Photodynamic therapy with PHOTOFRIN® being studied in range of cancers
CXR.TO: 93.51 (+5.21)
The Barbell Approach Builds Powerful Healthcare Stocks: StoneCastle's Bruce Campbell
Life Sciences Report - Seeking Alpha - Wed May 06, 8:49PM CDT
Portfolio manager Bruce Campbell wants the best of both worlds in his Canadian healthcare investments. He looks for companies that are strong and balanced, with muscular organic growth on one side and healthy acquisitions on the other. In this...
Concordia Healthcare Corp. to Host First Quarter 2015 Results Conference Call
CNW Group - Fri Apr 24, 6:00AM CDT
Concordia Healthcare Corp. ("Concordia" or "the Company" (TSX: CXR) (OTCQX: CHEHF), today announced it will release its first quarter 2015 financial results after market close on Thursday, May 14, 2015.
CXR.TO: 93.51 (+5.21)
Concordia Healthcare Corp. Announces Completion of Acquisition of Covis Pharma Commercial Assets for US$1.2 Billion
CNW Group - Tue Apr 21, 10:41AM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company" (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced that it has completed the previously announced acquisition by the Company of 18 products, being comprised of 12 branded products and five authorized generic contracts and a product distributed by a third party in Australia pursuant to the terms of a distribution agreement, from Covis Pharma S.a?.r.l and Covis Injectables, S.a?.r.l (collectively, "Covis" for $1.2 billion in cash (the "Acquisition". All financial references are in U.S. dollars unless otherwise noted.
CXR.TO: 93.51 (+5.21)
Concordia Healthcare Corp. announces upsizing and pricing of senior notes offering
CNW Group - Mon Apr 13, 4:21PM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company" (TSX:CXR)(OTCQX:CHEHF) announced today the upsizing and pricing of its previously announced offering of its 7.00% Senior Notes due 2023 (the "Notes". The principal amount of the Notes has been increased from US$610,000,000 to US$735,000,000 and the Notes were priced at an issue price of 100.00% of their face amount to yield 7.00%.
CXR.TO: 93.51 (+5.21)
OTC Markets Group Congratulates Concordia Healthcare Corporation on NASDAQ Listing
PR Newswire - Mon Jun 29, 3:30PM CDT
OTC Markets Group Inc. (OTCQX: OTCM) is pleased to congratulate Concordia Healthcare Corporation, a Canada-based specialty healthcare company, on its NASDAQ listing. Prior to joining NASDAQ, Concordia traded on the OTCQX® Best Marketplace operated by OTC Markets Group.
Concordia Healthcare Corp. Reports Results of Annual General Meeting of Shareholders
PR Newswire - Thu Jun 25, 4:00PM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company"
(TSX: CXR) (OTCQX: CHEHF), announced today that all of the nominees listed in the Company's Management Information Circular, dated May 25, 2015, for the 2015 Annual General Meeting of shareholders held on June 25, 2015, in Toronto, Ontario, (the "Meeting" were elected as members of Concordia's Board of Directors ("Board". The five (5) candidates nominated for election were elected by a majority of the shareholders present in person or represented by proxy at the Meeting, as follows: CXR.TO: 93.51 (+5.21)
Concordia Healthcare Corp. to Commence Trading on NASDAQ Global Select Market Under Symbol "CXRX"
CNW Group - Thu Jun 25, 6:00AM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company"
(TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced that its common shares will begin trading on the NASDAQ Global Select Market® ("NASDAQ" on June 29, 2015 under the symbol CXRX. CXR.TO: 93.51 (+5.21)
Concordia Healthcare Announces Filing for a U.S. Listing
PR Newswire - Tue Jun 02, 6:00AM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company"
(TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced that it has filed an application to list its common shares on the NASDAQ Global Select Market® ("NASDAQ", and has filed the requisite registration documentation with the U.S. Securities and Exchange Commission. CXR.TO: 93.51 (+5.21)
Concordia Healthcare Announces Changes to the Board of Directors, Management Team and Auditors
CNW Group - Mon May 25, 4:24PM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company"
(TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced several key changes to the Company's board of directors (the "Board" and management team. CXR.TO: 93.51 (+5.21)
Concordia Healthcare Corp. Announces First Quarter 2015 Results
CNW Group - Thu May 14, 4:48PM CDT
- First quarter 2015 revenue increase of 117% compared to the first quarter of 2014 -
CXR.TO: 93.51 (+5.21)
Concordia Healthcare Corp. works to expand treatment options for patients with rare cancers
CNW Group - Thu May 07, 6:00AM CDT
Photodynamic therapy with PHOTOFRIN® being studied in range of cancers
CXR.TO: 93.51 (+5.21)
The Barbell Approach Builds Powerful Healthcare Stocks: StoneCastle's Bruce Campbell
Life Sciences Report - Seeking Alpha - Wed May 06, 8:49PM CDT
Portfolio manager Bruce Campbell wants the best of both worlds in his Canadian healthcare investments. He looks for companies that are strong and balanced, with muscular organic growth on one side and healthy acquisitions on the other. In this...
Concordia Healthcare Corp. to Host First Quarter 2015 Results Conference Call
CNW Group - Fri Apr 24, 6:00AM CDT
Concordia Healthcare Corp. ("Concordia" or "the Company"
(TSX: CXR) (OTCQX: CHEHF), today announced it will release its first quarter 2015 financial results after market close on Thursday, May 14, 2015. CXR.TO: 93.51 (+5.21)
Concordia Healthcare Corp. Announces Completion of Acquisition of Covis Pharma Commercial Assets for US$1.2 Billion
CNW Group - Tue Apr 21, 10:41AM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company"
(TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced that it has completed the previously announced acquisition by the Company of 18 products, being comprised of 12 branded products and five authorized generic contracts and a product distributed by a third party in Australia pursuant to the terms of a distribution agreement, from Covis Pharma S.a?.r.l and Covis Injectables, S.a?.r.l (collectively, "Covis" for $1.2 billion in cash (the "Acquisition". All financial references are in U.S. dollars unless otherwise noted. CXR.TO: 93.51 (+5.21)
Concordia Healthcare Corp. announces upsizing and pricing of senior notes offering
CNW Group - Mon Apr 13, 4:21PM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company"
(TSX:CXR)(OTCQX:CHEHF) announced today the upsizing and pricing of its previously announced offering of its 7.00% Senior Notes due 2023 (the "Notes". The principal amount of the Notes has been increased from US$610,000,000 to US$735,000,000 and the Notes were priced at an issue price of 100.00% of their face amount to yield 7.00%. CXR.TO: 93.51 (+5.21)
